Retractable Technologies (NYSE:RVP) continued its descent into the red as 3rd-quarter losses mounted amid declining sales.
becton dickinson
BD announces management changes as Q4 profits slide on legal settlement
Becton Dickinson & Co. (NYSE:BDX) beat Wall Street’s estimates for its 4th quarter of 2013 and handed out a couple of promotions during the company’s quarterly conference call with investors.
U.K. healthcare regulators warn of ‘buckling’ Becton Dickinson catheters
Legal: Becton appeals $114M antitrust loss to Retractable Technologies
Becton Dickinson pays out nearly $8M in Retractable Technologies patent loss
Zimmer, Abbott, others rake in hundreds of millions in fed contracts
Federal agencies have handed out a slew of contracts and contract extensions in recent weeks, including about $370 million in deals for medical supplies and devices.
Retractable Technologies claims $114M win over Becton Dickinson in anti-trust lawsuit
Competitive bidding puts Medicare patients in jeopardy
By Catherine Burzik
The Centers for Medicare & Medicaid Services recently implemented the 2nd round of its so-called "competitive bidding" process, a system devised by Medicare to award supply contracts to providers of medical devices and products to patients in their homes.
Endo Health taps new CFO from Becton Dickinson | Personnel Moves